NAMUR, Belgium, Dec. 15, 2021 /PRNewswire/ — Dawn, a healthtech firm based in 2015 in Belgium, has simply closed a €3.25 million fundraising spherical. Led by Kurma Companions, this spherical of financing, during which the Vives-IUF fund linked to UCLouvain and Namur Make investments additionally participated, has the target of launching and internationally advertising the corporate’s first diagnostic product for sleep apnea. Along with this €3.25 million spherical of funding, there’s additionally €3.25 million in non-dilutive funding from the European Innovation Council, launched in 2021 by the European Fee to remodel scientific concepts into promising improvements, and the Walloon Area.
Sleep apnea is each one of the crucial vital and one of the crucial under-diagnosed situations on this planet. It impacts practically 1 billion folks worldwide. This public well being drawback impacts 49% of males and 23% of ladies over the age of 40. But, in 80% of instances, it stays undiagnosed regardless that it’s linked to critical ailments corresponding to hypertension, atrial fibrillation, strokes, diabetes and despair. On the request of the American Affiliation of Sleep Medication, a examine estimated the fee to society of an undiagnosed affected person at a mean of €6,366/12 months, in comparison with €2,105 if she or he is recognized.
A brand new fast and simple technique to diagnose sleep apnea.
To satisfy these wants, Dawn is creating a brand new resolution to analyze sleep utilizing a 3-gram sensor, coupled with Synthetic Intelligence. “We now have developed the measurement of a brand new biosignal: we analyze mandibular actions throughout sleep. The sensor communicates with a cellular software. The info collected is processed because of synthetic intelligence and may be transmitted to the physician the following morning. This protects time and makes analysis simpler” explains Laurent Martinot, co-founder and CEO of Dawn. CE Marked as licensed medical system, this sensor is much less intrusive and restrictive than a sleep check carried out in hospital with polysomnography. “Many consultants inform us that about 35% of sufferers do not go for it” provides Laurent Martinot.
Scientific and technological recognition within the USA
The system scientific validation was printed in JAMA – Journal of the American Medical Affiliation in 2020, with worldwide consultants presenting the sensor’s glorious efficiency by way of sensitivity and specificity. At the start of 2021, Dawn was awarded a prize within the “well being and well-being” class on the Client Electronics Present (CES) 2021 in Las Vegas. In the US, the answer is below revision by the FDA, whereas in France, the Haute Autorité de la Santé (French Well being Authority) is finding out the usage of the Dawn technologyfor quicker analysis in 14 main sleep facilities. The funds raised will probably be used to launch and market the system in these international locations.
“Due to the success of this fundraising, which brings collectively main traders, Dawn has reached a brand new stage in its improvement. It confirms the traders’ confidence within the group’s means to speed up the corporate’s technological improvement, to proceed to innovate and convey to market simpler to make use of, lighter and extra snug applied sciences for sleep apnea sufferers worldwide.”
Laurent Martinot, CEO of Dawn
“We’re happy to assist Dawn. The rigor and dedication of its groups made us imagine of their imaginative and prescient very early on. Sleep-disordered respiratory is an actual public well being difficulty: it is among the principal causes of significant sicknesses all through the world. Dawn is constructing the way forward for sleep analysis, to make it accessible to the biggest variety of folks and to assist docs take care of the rise within the variety of sleep checks linked to rising consciousness of this critical illness and the numerous prevalence of sleep issues within the inhabitants.”
Philippe Peltier, Accomplice at Kurma Companions
“For many years, the St. Elisabeth pulmonology middle (UCLouvain) has been engaged in analysis on sleep issues and has been highlighting these public well being points. Assembly this unmet medical want for sufferers is the mission of Dawn. This funding illustrates our need to advertise and speed up scientific breakthroughs on this complicated discipline by bringing collectively the strengths of academia, business and public authorities.”
Philippe Durieux, CEO Sopartec – VIVES Funds
Based in 2015 by Laurent and Pierre Martinot, Dawn goals to democratize entry to look after sleep apnea syndrome. This critical respiratory dysfunction is thought for multiplying mortality threat by issue 3. The Dawn innovation relies on greater than ten years of analysis : the know-how detects respiratory occasions primarily based on the evaluation of the respiratory drive (which is mirrored within the contractions of the respiratory muscular tissues and the actions these trigger on the stage of the chin). In 2021, it gained an award on the CES in Las Vegas. At present, about twenty folks (positioned in Belgium and France) work for Dawn, a scale-up that goals to market its medical system in the US and France.
 Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine Okay, Malhotra A (2019) Estimation of the worldwide prevalence and burden of obstructive sleep apnoea: a literature-based evaluation. Lancet Respir Med 7:687-698. – https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(19)30198-5.pdf
 Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered respiratory within the normal inhabitants: the HypnoLaus examine – https://pubmed.ncbi.nlm.nih.gov/25682233/
 Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine Okay, Malhotra A (2019) Estimation of the worldwide prevalence and burden of obstructive sleep apnoea: a literature-based evaluation. Lancet Respir Med 7:687-698. https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(19)30198-5.pdf
 Frost & Sullivan, Hidden Well being Disaster Costing America Billions (2016) – web page 4: https://aasm.org/assets/pdf/sleep-apnea-economic-crisis.pdf